MeredithPelsterMD

PubMed

• 21 citations
  Adagrasib in Advanced Solid Tumors Harboring aMutation.
  Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, Meredith S Pelster, Joshua K Sabari, Navid Hafez, Minal Barve, Karen Velastegui, Xiaohong Yan, Aditya Shetty, Hir...> ;Journal of Clinical Oncology. 2023 Sep 1
• 83 citations
  Adagrasib with or without Cetuximab in Colorectal Cancer with MutatedG12C.
  Rona Yaeger, Jared Weiss, Meredith S Pelster, Alexander I Spira, Minal Barve, Sai-Hong I Ou, Ticiana A Leal, Tanios S Bekaii-Saab, Cloud P Paweletz, Grace A Heavey, Ja...> ;The New England Journal of Medicine. 2023 Jan 5
• 129 citations
  Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.
  Meredith S. Pelster, Stephen K. Gruschkus, Roland L. Bassett, Dan S. Gombos, Michael Shephard, Liberty Posada, Maura S. Glover, Rinata Simien, Adi Diab, Patrick Hwu, B...> ;Journal of Clinical Oncology. 2021 Feb 20
• 7 citations
  Pembrolizumab-induced mucositis in a patient with recurrent hypopharynx squamous cell cancer.
  Meredith S. Pelster, Frank E. Mott, Jan S. Lewin> ;The Laryngoscope. 2020 Apr 1
• 11 citations
  Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
  Meredith S. Pelster, Rodabe N. Amaria> ;Current Treatment Options in Oncology. 2020 Feb 5
• 104 citations
  Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials:
  Meredith S. Pelster, Rodabe N. Amaria> ;Therapeutic Advances in Medical Oncology. 2019 Feb 19
• Join now to see all

Lectures

• Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM). 
  2019 ASCO Annual Meeting - 6/1/2019